175 related articles for article (PubMed ID: 25595575)
1. Renin-angiotensin system (RAS) blockade attenuates growth and metastatic potential of renal cell carcinoma in mice.
Araújo WF; Naves MA; Ravanini JN; Schor N; Teixeira VP
Urol Oncol; 2015 Sep; 33(9):389.e1-7. PubMed ID: 25595575
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the renin-angiotensin system downregulates tissue factor and vascular endothelial growth factor in human breast carcinoma cells.
Napoleone E; Cutrone A; Cugino D; Amore C; Di Santo A; Iacoviello L; de Gaetano G; Donati MB; Lorenzet R
Thromb Res; 2012 Jun; 129(6):736-42. PubMed ID: 22188725
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Renin-Angiotensin System Blockade on Renal Cell Carcinoma After Surgery.
Miyajima A; Yazawa S; Kosaka T; Tanaka N; Shirotake S; Mizuno R; Kikuchi E; Oya M
Ann Surg Oncol; 2015 Oct; 22(11):3751-9. PubMed ID: 25691280
[TBL] [Abstract][Full Text] [Related]
4. Renin angiotensin system blockade ameliorates lead nephropathy.
Ng HY; Tain YL; Lee YT; Hsu CY; Chiou TT; Huang PC; Lee CT
Biochem Biophys Res Commun; 2013 Aug; 438(2):359-63. PubMed ID: 23896603
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice.
Kubota M; Shimizu M; Sakai H; Yasuda Y; Ohno T; Kochi T; Tsurumi H; Tanaka T; Moriwaki H
Biochem Biophys Res Commun; 2011 Jun; 410(1):108-13. PubMed ID: 21640075
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
7. Long-term hemodynamic and molecular effects persist after discontinued renin-angiotensin system blockade in patients with type 1 diabetes mellitus.
Cherney DZ; Zinman B; Kennedy CR; Moineddin R; Lai V; Yang S; Miller JA; Prokopec SD; Boutros PC; Scholey JW; Reich HN
Kidney Int; 2013 Dec; 84(6):1246-53. PubMed ID: 23760288
[TBL] [Abstract][Full Text] [Related]
8. RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney.
Sachetelli S; Liu Q; Zhang SL; Liu F; Hsieh TJ; Brezniceanu ML; Guo DF; Filep JG; Ingelfinger JR; Sigmund CD; Hamet P; Chan JS
Kidney Int; 2006 Mar; 69(6):1016-23. PubMed ID: 16528251
[TBL] [Abstract][Full Text] [Related]
9. [Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers on angiogenesis of gastric cancer in a nude mouse model].
Wang L; Cai SR; Zhang CH; He YL; Zhan WH; Wu H; Peng JJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Nov; 11(6):565-8. PubMed ID: 19031137
[TBL] [Abstract][Full Text] [Related]
10. Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats.
Vaněčková I; Kujal P; Husková Z; Vaňourková Z; Vernerová Z; Certíková Chábová V; Skaroupková P; Kramer HJ; Tesař V; Červenka L
Kidney Blood Press Res; 2012; 35(5):382-92. PubMed ID: 22487948
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
12. Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells.
Yoshiji H; Yoshii J; Ikenaka Y; Noguchi R; Yanase K; Tsujinoue H; Imazu H; Fukui H
Int J Oncol; 2002 Jun; 20(6):1227-31. PubMed ID: 12012003
[TBL] [Abstract][Full Text] [Related]
13. Blockade of the renin-angiotensin system improves the early stages of liver regeneration and liver function.
Koh SL; Ager E; Malcontenti-Wilson C; Muralidharan V; Christophi C
J Surg Res; 2013 Jan; 179(1):66-71. PubMed ID: 23110972
[TBL] [Abstract][Full Text] [Related]
14. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
15. Changes in the renin angiotensin system during the development of colorectal cancer liver metastases.
Neo JH; Ager EI; Angus PW; Zhu J; Herath CB; Christophi C
BMC Cancer; 2010 Apr; 10():134. PubMed ID: 20380732
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of vasodilators in an animal model of chronic volume overload caused by severe aortic regurgitation.
Plante E; Lachance D; Beaudoin J; Champetier S; Roussel E; Arsenault M; Couet J
Circ Heart Fail; 2009 Jan; 2(1):25-32. PubMed ID: 19808312
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
18. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model.
Wang L; Cai SR; Zhang CH; He YL; Zhan WH; Wu H; Peng JJ
Chin Med J (Engl); 2008 Nov; 121(21):2167-71. PubMed ID: 19080179
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function.
Jover B; Mimran A
J Hypertens Suppl; 1994 Nov; 12(9):S3-9. PubMed ID: 7884582
[TBL] [Abstract][Full Text] [Related]
20. Add-on angiotensin receptor blockade with maximized ACE inhibition.
Agarwal R
Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]